CYP2C8-derived epoxyeicosatrienoic acids decrease oxidative stress-induced endothelial apoptosis in development of atherosclerosis: Role of Nrf2 activation

Abstract

The aim of the present study is to investigate how cytochrome P450 enzymes (CYP) 2C8-derived epoxyeicosatrienoic acids (EETs) regulate the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway and protect against oxidative stress-induced endothelial injuries in the development and progression of atherosclerosis. In this study, cultured human umbilical vein endothelial cells (HUVECs) were transfected with CYP2C8 or pretreated with exogenous EETs (1 μmol/L) before TNF-α (20 ng/mL) stimulation. Apoptosis and intracellular ROS production were determined by flow cytometry. The expression levels of ROS-associated NAD(P)H subunits gp91 and p47, the anti-oxidative enzyme catalase (CAT), Nrf2, heme oxygenase-1 (HO-1) and endothelial nitric oxide synthase (eNOS) were detected by Western blotting. The results showed that CYP2C8-derived EETs decreased apoptosis of HUVECs treated with TNF-α. Pretreatment with 11, 12-EET also significantly blocked TNF-α-induced ROS production. In addition, 11, 12-EET decreased oxidative stress-induced apoptosis. Furthermore, the ability of 11, 12-EET to protect cells against TNF-α-induced apoptosis via oxidative stress was abrogated by transient transfection with Nrf2-specific small interfering RNA (siRNA). In conclusion, CYP2C8-derived EETs prevented TNF-α-induced HUVECs apoptosis via inhibition of oxidative stress associated with the Nrf2 signaling.

Keywords

cytochrome P450 enzymes 2C8 / epoxyeicosatrienoic acids / apoptosis / reactive oxygen species / nuclear factor erythroid 2-related factor 2 / atherosclerosis

References

[1] RossR. AS—an inflammatory disease. N Engl J Med, 1999, 340(2): 115-126

[2] DuG, SongY, ZhangT, et al.. Simvastatin attenuates TNFalpha-induced apoptosis in endothelial progenitor cells via the upregulation of SIRT1. Int J Mol Med, 2014, 34(1): 177-182

[3] TanY, WangQ, SheY, et al.. Ketamine reduces LPS-induced HMGB1 via activation of the Nrf2/HO-1 pathway and NF-kappaB suppression. J Trauma Acute Care Surg, 2015, 78(4): 784-792

[4] JayachandranM, ChandrasekaranB, NamasivayamN. Geraniol attenuates oxidative stress by Nrf2 activation in diet-induced experimental AS. J Basic Clin Physiol Pharmacol, 2015, 26(4): 335-346

[5] SurhYJ, KunduJK, LiMH, et al.. Role of Nrf2-mediated heme oxygenase-1 upregulation in adaptive survival response to nitrosative stress. Arch Pharm Res, 2009, 32(8): 1163-1176

[6] LiuW, WangB, DingH, et al.. A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-alpha activity. Int J Mol Med, 2014, 34(3): 725-732

[7] ForstermannU. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med, 2008, 5(6): 338-349

[8] CaiH. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res, 2005, 68(1): 26-36

[9] AlvarezRJ, GipsSJ, MoldovanN, et al.. 17beta-estradiol inhibits apoptosis of endothelial cells. Biochem Biophys Res Commun, 1997, 237(2): 372-381

[10] ChoyJC, GranvilleDJ, HuntDW, et al.. Endothelial cell apoptosis: biochemical characteristics and potential implications for AS. J Mol Cell Cardiol, 2001, 33(9): 1673-1690

[11] XuX, ZhangXA, WangDW. The roles of CYP450 epoxygenases and metabolites,epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Adv Drug Deliv Rev, 2011, 63(8): 597-609

[12] JungO, BrandesRP, KimIH, et al.. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension. Hypertension, 2005, 45(4): 759-765

[13] UluA, DavisBB, TsaiHJ, et al.. Soluble epoxide hydrolase inhibitors reduce the development of AS in apolipoprotein e-knockout mouse model. J Cardiovasc Pharmacol, 2008, 52(4): 314-323

[14] HulsmansM, HolvoetP. The vicious circle between oxidative stress and inflammation in AS. J Cell Mol Med, 2010, 14(1–2): 70-78

[15] LermanA, ZeiherAM. Endothelial function: cardiac events. Circulation, 2005, 111(3): 363-368

[16] UngvariZ, Bailey-DownsL, GautamT, et al.. Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Am J Physiol Heart Circ Physiol, 2011, 300(4): 1133-1140

[17] Howden R. Nrf2 and cardiovascular defense. Oxid Med Cell Longev, 2013,2013:104308

[18] ChenB, LuY, ChenY, et al.. The role of Nrf2 in oxidative stress-induced endothelial injuries. J Endocrinol, 2015, 225(3): R83-R99

[19] DaiG, VaughnS, ZhangY, et al.. Biomechanical forces in AS-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ Res, 2007, 101(7): 723-733

[20] JuurlinkBH. Dietary Nrf2 activators inhibit atherogenic processes. Atherosclerosis, 2012, 225(1): 29-33

[21] ZrelliH, KusunokiM, MiyazakiH. Role of Hydroxytyrosol- dependent regulationof HO-1 expression in promoting wound healing of vascular endothelial cells via Nrf2 de novo synthesis and stabilization. Phytother Res, 2015, 29(7): 1011-1018

[22] HosoyaT, MaruyamaA, KangMI, et al.. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J Biol Chem, 2005, 280(29): 27244-27250

[23] Bailey-DownsLC, MitschelenM, SosnowskaD, et al.. Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging. J Gerontol A BiolSci Med Sci, 2012, 67(4): 313-329

[24] HarrisonDG, WidderJ, GrumbachI, et al.. Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med, 2006, 259(4): 351-363

[25] LeeSE, JeongSI, YangH, et al.. Extract of Salvia miltiorrhiza (Danshen) induces Nrf2-mediated heme oxygenase-1 expression as a cytoprotective action in RAW 264.7 macrophages. J Ethnopharmacol, 2012, 139(2): 541-548

[26] ChenJS, HuangPH, WangCH, et al.. Nrf-2-mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract. Atherosclerosis, 2011, 214(2): 301-309

[27] SiowRC, SatoH, MannGE. Hemeoxygenase-carbon monoxide signaling pathway in AS: anti-atherogenic actions of bilirubin and carbon monoxide. Cardiovasc Res, 1999, 41(2): 385-394

[28] ZrelliH, MatsuokaM, KitazakiS, et al.. Hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: role of Nrf2 activation and HO-1 induction. J Agric Food Chem, 2011, 59(9): 4473-4482

[29] WuML, HoYC, LinCY, et al.. Heme oxygenase-1 in inflammation and cardiovascular disease. Am J Cardiovasc Dis, 2011, 1(2): 150-158

[30] BeltowskiJ, JamrozA, BorkowskaE. Hemeoxygenase and carbon monoxide in the physiology and pathology of the cardiovascular system. Postepy Hig Med Dosw (Online), 2004, 58: 83-99

[31] LiT, TianH, ZhaoY, et al.. Heme oxygenase-1 inhibits progression and destabilization of vulnerable plaques in a rabbit model of AS. Eur J Pharmacol, 2011, 672(1–3): 143-152